Welcome to the international HTA database

Showing [18609 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2003	Blue Cross Blue Shield Association (BCBS)	Use of intermittent or continuous interstitial fluid glucose monitoring in patients with diabetes mellitus
2002	Blue Cross Blue Shield Association (BCBS)	Use of intermittent or continuous interstitial fluid glucose monitoring in patients with diabetes mellitus
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Use of lidocaine on adults with open wounds: a review of the safety
2006	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Use of liposomal cytarabine (DepoCyte®) within NHS Wales
2001	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	Use of mammography and Papanicolaou's test for the early detection of breast and uterine cervix cancer in Spain. IPE-02/34 (Public report)
2009	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Use of matrix coils in the treatment of cerebro-vascular aneurysms: an update
2013	Center for Evidence-based Practice (CEP)	Use of midodrine with vasopressors in the intensive care unit
2006	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Use of mycophenolic acid as a sodium salt (Myfortic®) within NHS Wales
2013	Agency for Healthcare Research and Quality (AHRQ)	Use of natriuretic peptide measurement in the management of heart failure
2013	HAYES, Inc.	Use of negative-displacement needleless connectors and rates of catheter-related bloodstream infections
2013	HAYES, Inc.	Use of neutral-displacement needleless connectors and rates of catheter-related bloodstream infections
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Use of new versus refurbished surgical tables: comparative clinical effectiveness and guidelines
2013	HTA Unit, University of Calgary	Use of Oncotype DX for guiding adjuvant chemotherapy decisions in early stage invasive breast cancer patients in Alberta
2010	Center for Evidence-based Practice (CEP)	Use of opioids for treating chronic back pain
2010	Center for Evidence-based Practice (CEP)	Use of opioids for treatment of fibromyalgia
2003	Norwegian Knowledge Centre for the Health Services (NOKC)	Use of palliative surgery in the treatment of cancer patients
2005	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Use of Pegvisomant (Somavert®) within NHS Wales
2016	Belgian Health Care Knowledge Centre (KCE)	Use of pneumococcal vaccines in the elderly an economic evaluation
2009	Belgian Health Care Knowledge Centre (KCE)	Use of point-of-care devices in patients with oral anticoagulation : a Health Technology Assessment
1999	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	Use of polymerase chain reaction
2013	HAYES, Inc.	Use of positive-displacement needleless connectors and rates of catheter-related bloodstream infections
2001	Agency for Healthcare Research and Quality (AHRQ)	Use of positron emission tomography and other neuroimaging techniques in the diagnosis and management of Alzheimer's disease and dementia
2006	Finnish Office for Health Care Technology Assessment (Finohta)	Use of quality-adjusted life years for the estimation of effectiveness of health care: a systematic literature review
2007	Andalusian Health Technology Assessment Area (AETSA)	Use of recombinant human erythropoietin in orthopedic surgery
2000	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Use of resources for oncologic patients during last month of life: the role of PADES (home care and support teams programme)
2012	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Use of serum procalcitonin levels in treatment decisions for adult patients in the intensive care unit
2007	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Use of sodium phenylbutyrate within NHS Wales
2007	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Use of sorafenib (Nexavar®) for advanced renal cell carcinoma within NHS Wales
2005	Agency for Healthcare Research and Quality (AHRQ)	Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD)
2003	Quality Improvement Scotland (NHS QIS )	Use of stents to treat peripheral arterial disease (PAD)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Use of surgical masks in the operating room: a review of the clinical effectiveness and guidelines
2015	Canadian Agency for Drugs and Technologies in Health (CADTH)	Use of the Braden Scale for assessing pressure ulcer risk in acute care: clinical evidence and guidelines
2004	Andalusian Health Technology Assessment Area (AETSA)	Use of the drug eluting stents - review
2003	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Use of the implantable cardiac defibrillator (ICD) at the McGill University Health Centre (MUHC)
2011	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Use of the VerifyNow point of care test to detect nonresponsiveness to clopidogrel and aspirin
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Use of topical anesthetics for suturing and circumcisions in pediatric patients: a review of clinical effectiveness and guidelines
2001	Norwegian Knowledge Centre for the Health Services (NOKC)	Use of ultrasonography in the primary health care setting
2004	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	Use of ultrasound in antenatal and primary care
2000	Canadian Task Force on Preventive Health Care (CTFPHC)	Use of varicella vaccine in healthy populations: systematic review and recommendations
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of alpha-glucosidase in pompe disease
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of alpha-glucosidase in Pompe disease
2004	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of autologous growth factors in orthopaedic surgery
2004	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of bevacizumab in colon cancer patients
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of ceramic or metal on metal prostheses in total hip replacement
2005	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of ceramic prosthesis in total hip replacement
2004	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of extracorporeal shock waves in musculoskeletal disorders
2008	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of high-intensity focused ultrasound in prostate cancer
2005	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of hip arthroscopy
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of hippotherapy
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of hydroxyethyl starch (HES) as plasma expander
2007	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of intervertebral disc prostheses for spine diseases
2005	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of multislice computed tomography (MSCT) for coronary disease
2007	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of multislice computed tomography (MSCT) for coronary disease
2008	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of multislice computed tomography for the assessment of liver metastases
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of music therapy in clinical practice
2008	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of pacemakers with managed 'ventricular pacing mode'
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of plasminogen activator inhibitor 4G/5G polymorphism testing in recurrent miscarriage
2005	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of radiofrequency ablation of liver tumors
2008	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of real-time PCR for the monitoring of chronic myeloid leukemia patient
2008	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of real-time PCR in acute promyelocytic leukemia patient monitoring
2007	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of SPECT in epilepsy
2007	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of SPECT in epilepsy
2004	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of surgical treatments for obesity
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of synthetic graft in knee anterior cruciate ligament reconstruction
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of thalidomide for the management of sarcomas
2007	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of the European Appropriateness Evaluation Protocol (AEP)
2013	Health Quality Ontario (HQO)	Usefulness of urinary antigen testing for Legionella in the treatment of community-acquired pneumonia: a rapid review
2008	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of varenicline in smoking cessation therapy
2005	Institute for Clinical Effectiveness and Health Policy (IECS)	Usefulness of video capsule gastrointestinal endoscopy in digestive bleeding of unknown origin
2001	Agency for Healthcare Research and Quality (AHRQ)	Uses of epoetin for anemia in oncology
2002	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Using a spectral reflectance technique to measure transcutaneous bilirubin in neonates: a new device
2015	NIHR Health Services and Delivery Research programme	Using clinical practice variations as a method for commissioners and clinicians to identify and prioritise opportunities for disinvestment in health care: a cross-sectional study, systematic reviews and qualitative study
2020	NIHR Health Services and Delivery Research programme	Using co-production to improve patient carer and staff experiences in health care organizations: a multi-centre, mixed methods evaluation in inpatient stroke units (CREATE)
2007	Quality Improvement Scotland (NHS QIS )	Using data to improve surgical care - the surgical profiles project
2005	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	Using decision-analytic modelling to transfer international evidence from health technology assessment to the context of the German health care system
2005	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	Using decision-analytic modelling to transfer international evidence from health technology assessment to the context of the German health care system
2008	Institute of Health Economics (IHE)	Using fetal fibronectin to diagnose pre-term labour
2006	Alberta Heritage Foundation for Medical Research (AHFMR)	Using HTA to identify research gaps: a pilot study
2018	Center for Evidence-based Practice (CEP)	Using Patient Generated Health Data in an Electronic Health Record
2000	NIHR Health Technology Assessment programme	Using routine data to complement and enhance the results of randomised controlled trials
2005	Israel Center for Technology Assessment in Health Care (ICTAHC)	Using the literature to forecast utilization of emerging technologies (abstract)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Ustekinumab (Stelara — Janssen Inc.) indication: psoriatic arthritis
2016	HAYES, Inc.	Ustekinumab (Stelara; Janssen Biotech Inc.) for treatment of psoriatic arthritis
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Ustekinumab (Stelara) for Crohn's disease
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Ustekinumab (Stelara) for plaque psoriasis in adolescents
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Ustekinumab (Stelara) for psoriatic arthritis
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Ustekinumab (Stelara) for psoriatic arthritis - second line after disease modifying anti-rheumatic drugs (DMARDs)
2019	European Network for Health Technology Assessment (EUnetHTA)	Ustekinumab for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response with, lost response to or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies
2009	National Institute for Health and Clinical Excellence (NICE)	Ustekinumab for the treatment of adults with moderate to severe psoriasis
2009	NIHR Health Technology Assessment programme	Ustekinumab for the treatment of moderate to severe psoriasis
2013	NIHR Health Technology Assessment programme	Ustekinumab for treating active and progressive psoriatic arthritis
2005	Agency for Healthcare Research and Quality (AHRQ)	Usual care in the management of chronic wounds: a review of the recent literature
2003	Wessex Institute for Health Research and Development (WIHRD)	Uterine artery embolisation for fibroids
2003	National Institute for Clinical Excellence (NICE)	Uterine artery embolisation for fibroids
2010	National Institute for Health and Clinical Excellence (NICE)	Uterine artery embolisation for fibroids
2004	National Institute for Clinical Excellence (NICE)	Uterine artery embolisation for the treatment of fibroids
2006	Adelaide Health Technology Assessment (AHTA)	Uterine artery embolisation for the treatment of symptomatic uterine fibroids
2009	HAYES, Inc.	Uterine artery embolization
2006	Institute for Clinical Effectiveness and Health Policy (IECS)	Uterine artery embolization for the management of uterine fibroids
2002	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Uterine artery embolization for the treatment of fibroids